09/20/2007 - BioShield also provided for grants to modernize existing biomedical and behavioral research facilities and construct new ones. It gave authority to the federal government to procure critical drugs using specially designated funds. In addition, BioShield amended the Federal Food, Drug, and Cosmetic Act (FFDCA) to allow specific drugs to be introduced to the public prior to FDA approval, provided the Homeland Security Secretary determined that a national emergency merited the use of such drugs.
09/20/2007 - A new Missouri law (formerly H.B. 413) requires that the state set up a vaccination program for first responders who would be deployed to disaster areas as a result of bioterrorism. Participation in the program is voluntary except for those first responders identified by their employers as personnel who cannot safely perform their emergency duties without the vaccinations
09/19/2007 - The database is part of a larger initiative to evaluate public health preparedness and educate officials on methods for improvement. Rand has also produced studies that evaluate public health preparedness, test public health disease reporting systems, and create best practices for public health officials.
09/14/2007 - Over one-quarter of states do not have sufficient bioterrorism laboratory response capabilities,” says the third annual study of the U.S. public health and emergency response capabilities by the Trust for America’s Health. The report brings to light several deficiencies in the public health sector and evaluates states’ abilities to respond to and mitigate the effects of a natural disaster or terrorist incident. @ The full report is available via SM Online.